BB Biotech (Switzerland) Market Value
| BION Stock | CHF 37.30 0.25 0.67% |
| Symbol | BION |
BB Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BB Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BB Biotech.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in BB Biotech on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding BB Biotech AG or generate 0.0% return on investment in BB Biotech over 30 days. BB Biotech is related to or competes with Swiss Life, Swiss Re, Helvetia Holding, Partners Group, and Straumann Holding. BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG More
BB Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BB Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BB Biotech AG upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 6.87 | |||
| Value At Risk | (2.29) | |||
| Potential Upside | 1.77 |
BB Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BB Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BB Biotech's standard deviation. In reality, there are many statistical measures that can use BB Biotech historical prices to predict the future BB Biotech's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.12) |
BB Biotech AG Backtested Returns
BB Biotech AG retains Efficiency (Sharpe Ratio) of -3.0E-4, which signifies that the company had a -3.0E-4% return per unit of price deviation over the last 3 months. BB Biotech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BB Biotech's Market Risk Adjusted Performance of (0.11), information ratio of (0.13), and Variance of 1.68 to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BB Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding BB Biotech is expected to be smaller as well. At this point, BB Biotech AG has a negative expected return of -4.0E-4%. Please make sure to confirm BB Biotech's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if BB Biotech AG performance from the past will be repeated sooner or later.
Auto-correlation | 0.21 |
Weak predictability
BB Biotech AG has weak predictability. Overlapping area represents the amount of predictability between BB Biotech time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BB Biotech AG price movement. The serial correlation of 0.21 indicates that over 21.0% of current BB Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.37 |
BB Biotech AG lagged returns against current returns
Autocorrelation, which is BB Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BB Biotech's stock expected returns. We can calculate the autocorrelation of BB Biotech returns to help us make a trade decision. For example, suppose you find that BB Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BB Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BB Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BB Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BB Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
BB Biotech Lagged Returns
When evaluating BB Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BB Biotech stock have on its future price. BB Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BB Biotech autocorrelation shows the relationship between BB Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in BB Biotech AG.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.